Pfizer, Medicines for Malaria Venture pact for malaria prevention during pregnancy
Pfizer Inc and Medicines for Malaria Venture (MMV) has entered into an agreement for the development, access and delivery of a fixed-dose combination treatment consisting of azithromycin dihydrate (AZ) and chloroquine phosphate (CQ) for the Intermittent Preventive Treatment of P. falciparum malaria in pregnancy (IPTp).

Read more on PharmaBiz